DUBLIN, April 21, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" report to their offering.
This report discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current market drivers and restraints, mergers and acquisitions (M&A) activity and recent regulatory developments in key national markets.
Furthermore, this report analyses leading therapeutic segments in the OTC drugs market, key brands, manufacturers and the potential for new product categories to be created as more prescription-only drugs from diverse therapy areas continue to be considered for OTC approval. Detailed case studies of recent Rx-to-OTC switches provide the rationale for these switches including description of their economic and financial impact.
The OTC drugs market remains highly competitive and fragmented albeit leading companies continue to consolidate their market position through high-profile and strategic acquisitions. We expect M&A to remain very active in the coming years fueled by strategic long-term commercial priorities, as companies look to increase revenues through expanded OTC portfolios. A positive regulatory outlook in key markets, due to new initiatives and frameworks looking to facilitate OTC approvals, will also prompt companies to seek access to new markets.
The global OTC drugs market will continue to be largely driven by demographics, economic trends and changes in cultural attitudes towards self-medication. An increasing interest in self-medication in both developed and developing countries has been identified as a major contributor to market growth in recent years.
We conducted extensive primary and secondary research efforts in order to provide a comprehensive view of the regulatory, commercial and competitive landscape in the OTC drugs market. Our new report will let you assess the most promising commercial areas in the market and help you identify key opportunities and challenges.
Scope
- How do consumers, payers and manufacturers benefit from Rx-to-OTC switches?
- What are the key factors promoting the usage of OTC drugs?
- Current trends in the OTC drugs market
- What attitudes do consumers have towards OTC drugs?
- How are new distribution channels, technologies and education reshaping the OTC drugs market?
- What will be the impact of new regulatory initiatives and frameworks on future Rx-to-OTC switches in key markets?
- What have been the preferred types of M&A deals in the OTC drugs market in recent years?
- Which OTC drug manufacturers have been the most active in terms of mergers and acquisitions in recent years?
- What are the current regulations and frameworks established in key developed and developing markets for OTC approval and Rx-to-OTC switches?
- Which OTC drug product categories and drug classes have experienced the most switches in recent years?
- Which new products categories are expected to enter the OTC drugs market in the coming years?
- What has been the economic and financial impact of recent Rx-to-OTC switches?
- Who are the leading OTC drug manufacturers and what are their OTC segments of interest?
Key Topics Covered:
- Key Global Trends in the OTC Drugs Market
- APAC (India, China, Japan)
- M&A Activity in the OTC Drugs Market: Leading Companies Consolidating their Market Position
- Deal Analysis by Value, Type and Subtype
- Drivers of the OTC Drugs Market
- Barriers of the OTC Drugs Market
- Current Regulations Surrounding OTC Drugs and Rx-to-OTC Switches
- Recent Regulatory Trends and Developments in the OTC Drugs Market
- Impact of Initiatives and Regulations (NSURE, Affordable Care Act) on Future Rx-to-OTC Switches
- Rx-to-OTC Switch Case Studies: Key Benefits, Economic and Financial Impact
- Nexium 24HR
- Nasacort Allergy 24HR
- Rhinocort Nasal Spray
- Oxytrol For Women
- Nicotine Replacement Therapies
- Future Trends in the OTC Drugs Market and Rx-to-OTC Switches
- Potential Drug Candidates for Future Rx-to-OTC Switch
- Leading OTC Drug Manufacturers and Segments of Interest
- Importance of Rx-to-OTC Strategies
- Life Sciences Companies
- Pharmacies
- Others
- Leading Product Categories in the OTC Drugs Market
- Cough, Cold and Allergy OTC Drugs
- Leading Brands and Key Manufacturers
- Market Analysis
- Analgesic OTC Drugs
- Leading Brands and Key Manufacturers
- Dermatology OTC Drugs
- Leading Brands and Key Manufacturers
- Gastrointestinal OTC Drugs
- Leading Brands and Key ManufacturersFor more information visit http://www.researchandmarkets.com/research/6rvmbs/the_otc_drugs
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article